Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry.
Fujiwara T, Kondo M, Yamada H, Haraguchi A, Fujimura K, Sakuraba K, Kamura S, Fukushi JI, Miyahara H, Inoue Y, Tsuru T, Shuto T, Yoshizawa S, Suematsu E, Miyamura T, Ayano M, Mitoma H, Arinobu Y, Niiro H, Ohishi M, Hirata A, Tokunaga S, Takada A, Hara D, Tsushima H, Akasaki Y, Ikemura S, Sueishi T, Toya M, Sakuragi T, Tsutsui T, Kai K, Arisumi S, Nakashima Y. Fujiwara T, et al. Among authors: suematsu e. Arthritis Res Ther. 2022 Feb 22;24(1):53. doi: 10.1186/s13075-022-02746-5. Arthritis Res Ther. 2022. PMID: 35193646 Free PMC article.
Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate.
Nakashima Y, Kondo M, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Nagamine R, Nakashima H, Otsuka T, Saikawa I, Shono E, Suematsu E, Tsuru T, Wada K, Iwamoto Y. Nakashima Y, et al. Among authors: suematsu e. Mod Rheumatol. 2010 Aug;20(4):343-52. doi: 10.1007/s10165-010-0290-x. Epub 2010 May 18. Mod Rheumatol. 2010. PMID: 20480201
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: suematsu e. Mod Rheumatol. 2014 Mar;24(2):258-64. doi: 10.3109/14397595.2013.854069. Mod Rheumatol. 2014. PMID: 24593201 Clinical Trial.
Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
Hirata A, Suenaga Y, Miyamura T, Matsui T, Tohma S, Suematsu E, Ohnaka K, Takayanagi R. Hirata A, et al. Among authors: suematsu e. Int J Rheum Dis. 2018 Apr;21(4):828-835. doi: 10.1111/1756-185X.12877. Epub 2016 Apr 29. Int J Rheum Dis. 2018. PMID: 27126059
Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.
Nakashima Y, Miyahara H, Kondo M, Fukuda T, Harada H, Haraguchi A, Inoue Y, Ishinishi T, Maekawa M, Maeyama A, Nakashima M, Shono E, Suematsu E, Shimauchi T, Tsuru T, Tsukamoto H, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: suematsu e. Mod Rheumatol. 2017 Jan;27(1):15-21. doi: 10.3109/14397595.2016.1170958. Epub 2016 May 4. Mod Rheumatol. 2017. PMID: 27142240
Latent psychological distress existing behind a set of assessment measures is comparable to or more important than symptoms or disability in the association with quality of life and working status of patients with rheumatoid arthritis.
Hirata A, Miyamura T, Suenaga Y, Katayama M, Suematsu E, Tohma S. Hirata A, et al. Among authors: suematsu e. Mod Rheumatol. 2018 Nov;28(6):968-975. doi: 10.1080/14397595.2018.1428043. Epub 2018 Mar 2. Mod Rheumatol. 2018. PMID: 29325472
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.
Nakashima Y, Kondo M, Shono E, Ishinishi T, Tsukamoto H, Kuroda K, Maeyama A, Harada H, Maekawa M, Shimauchi T, Nagamine R, Jojima H, Yoshizawa S, Tsuru T, Otsuka T, Miyahara H, Suematsu E, Wada K, Yoshizawa S, Inoue Y, Fukuda T, Ikemura S, Haraguchi A. Nakashima Y, et al. Among authors: suematsu e. Mod Rheumatol. 2020 Sep;30(5):807-815. doi: 10.1080/14397595.2019.1676369. Epub 2019 Oct 17. Mod Rheumatol. 2020. PMID: 31580188
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: suematsu e. Mod Rheumatol. 2013 Apr 8. doi: 10.1007/s10165-013-0878-z. Online ahead of print. Mod Rheumatol. 2013. PMID: 23563508
107 results